Knowledge Hub

​2016 - 2022 Growth Of Peptic Ulcer Drugs Market Globally

Press Release   •   Aug 14, 2017 06:31 EDT

About Peptic Ulcer Drugs Market

Peptic ulcer disease represents a group of ulcerative disorders such as gastritis, gastric ulcers, and duodenal ulcers or gastroesophageal reflux disease (GERD). Treatment of peptic ulcers is achieved through drugs such as proton pump inhibitors (PPI), potassium-competitive acid blockers (P-CAB), antacid, H2-antagonist, antibiotics, and ulcer protective drugs such as sucralfate. Increasing usage of non-steroidal anti-inflammatory drugs such as aspirin due to increasing inflammatory conditions is the major factor driving the growth of the global peptic ulcer drugs market. However, side effects of long-term use of PPIs, changing government policies, loss of market exclusivity of a majority of peptic ulcer drugs, and limited R&D efforts in the field of peptic ulcer drugs are factors expected to hamper the growth of peptic ulcer drugs market, globally.

The peptic ulcer drugs market is segmented as follows:

By Product Type

By Disease Indication

By Distribution Channels

By Region

Get Sample copy of this Report @

This report covers the global peptic ulcer drugs market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global peptic ulcer drugs market over the forecast period. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to provide clients with crystal clear decision-making insights.

Based on product type, the global peptic ulcer drugs market is segmented into proton pump inhibitors (PPI), potassium-competitive acid blockers (P-CAB), antacids, ulcer protective drugs, H2-antagonists, and antibiotics. The PPIs segment is expected to remain the dominant segment in terms of value during the forecast period.

By disease indication, the global peptic ulcer drugs market is segmented as gastritis, gastric ulcer, duodenal ulcer or gastroesophageal reflux disease (GERD). GERD segment is expected to dominate in terms of market share contribution, accounting for the maximum share of the overall market by 2022 end; whereas revenue from gastric ulcer segment is projected to expand at highest CAGR of during the forecast period.

On the basis of the distribution channel, hospital pharmacies segment is expected to hold maximum market share in the global market for peptic ulcer drugs.

View Sample PDF @

By region, the market in North America is expected to lead in the global peptic ulcer drugs market. In 2014, North America and Europe collectively accounted for 67% share of overall marker revenue. Asia Pacific market accounted for 22% share in global peptic ulcer drugs market and is expected to gain significant market share over the forecast period, due to increasing recurrence of peptic ulcer disease. The MEA market is expected to witness sluggish growth during the forecast period partly due to low accessibility to peptic ulcer drugs in the region.

Key segments covered

Product Type

Proton Pump Inhibitors (PPIs)

Potassium-Competitive Acid Blockers




Ulcer Protective Drugs

Disease Indication


Gastric Ulcer

Duodenal Ulcer

Gastroesophageal Reflux Disease (GERD)

Distribution Channel

Hospital Pharmacies

Private Clinics

Drug Stores

Retail Pharmacies


Key Regions/Countries Covered

North America










Rest of Europe

Asia Pacific





South Korea

Rest of Asia Pacific

Latin America




Rest of Latin America


GCC Countries

South Africa

Rest of MEA

Key features included in this report

Send An Enquiry Request @

Drivers and restraints of the peptic ulcer drugs market

Pipeline analysis and key developments in the market

Analysis of business strategies of key players

Peptic ulcer drugs market estimates and forecast

Table of Content

1. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Peptic Ulcer Drugs Market Overview

4.1. Introduction

4.1.1. Peptic Ulcer Drugs Market Definition

4.1.2. Peptic Ulcer Drugs Market Taxonomy

4.2. Peptic Ulcer Drugs Market Product Overview

4.3. Parent Market Overview

4.4. PEST Analysis

4.5. Disease Epidemiology, By Regions

4.6. Regulations

4.7. Product Margin Analysis

4.8. Peptic Ulcer Drugs Market Dynamics

4.8.1. Drivers

4.8.2. Restraints

4.8.3. Opportunity

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.